Skip to main content

Treatment for Fecal Incontinence: Nonsurgical Approaches

  • Chapter
  • First Online:
Female Pelvic Medicine

Abstract

Fecal incontinence is defined as greater than 1 month of uncontrolled passage of fecal material or gas in a person age 4 years or older, who previously achieved control. Treatment of fecal incontinence can be challenging and should be individualized. This chapter discusses the general approaches to the management of fecal incontinence with a focus on nonoperative management. More invasive approaches such as replacement, repair, augmentation, stimulation, and fecal diversion are outlined.

Commentary by Tracy L. Hull, Cleveland Clinic, Department of Colon and Rectal Surgery, Cleveland, OH, USA

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Paquette IM, Varma MG, Kaiser AM, Steele SR, Rafferty JF. The American Society of Colon and Rectal Surgeons’ clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015;58(7):623–36.

    Article  PubMed  Google Scholar 

  2. Ditah I, Devaki P, Luma HN, et al. Prevalence, trends, and risk factors for fecal incontinence in United States adults, 2005-2010. Clin Gastroenterol Hepatol. 2014;12(4):636–43.

    Article  PubMed  Google Scholar 

  3. Goode PS, Burgio KL, Halli AD, et al. Prevalence and correlates of fecal incontinence in community-dwelling older adults. J Am Geriatr Soc. 2005;53(4):629–35.

    Article  PubMed  Google Scholar 

  4. Markland AD, Goode PS, Burgio KL, et al. Incidence and risk factors for fecal incontinence in black and white older adults: a population-based study. J Am Geriatr Soc. 2010;58(7):1341–6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Whitehead WE, Borrud L, Goode PS, et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology. 2009;137(2):512–7, 517.e1–2.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Nelson RL. Epidemiology of fecal incontinence. Gastroenterology. 2004;126(1 Suppl 1):S3–7.

    Article  PubMed  Google Scholar 

  7. Menees SB, Almario CV, Spiegel BMR, Chey WD. Prevalence of and factors associated with fecal incontinence: results from a population-based survey. Gastroenterology. 2018;154(6):1672–1681.e3.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Brown HW, Wexner SD, Segall MM, Brezoczky KL, Lukacz ES. Accidental bowel leakage in the mature women’s health study: prevalence and predictors. Int J Clin Pract. 2012;66(11):1101–8.

    Article  CAS  PubMed  Google Scholar 

  9. Pinto RA, Sands DR. Surgery and sacral nerve stimulation for constipation and fecal incontinence. Gastrointest Endosc Clin N Am. 2009;19(1):83–116, vi–vii.

    Article  PubMed  Google Scholar 

  10. Townsend MK, Matthews CA, Whitehead WE, Grodstein F. Risk factors for fecal incontinence in older women. Am J Gastroenterol. 2013;108(1):113–9.

    Article  PubMed  Google Scholar 

  11. Bharucha AE, Fletcher JG, Melton LJ 3rd, Zinsmeister AR. Obstetric trauma, pelvic floor injury and fecal incontinence: a population-based case-control study. Am J Gastroenterol. 2012;107(6):902–11.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Jorge JM, Wexner SD. Etiology and management of fecal incontinence. Dis Colon Rectum. 1993;36(1):77–97.

    Article  CAS  PubMed  Google Scholar 

  13. Brown HW, Wexner SD, Lukacz ES. Factors associated with care seeking among women with accidental bowel leakge. Female Pelvic Med Reconstr Surg. 2013;19(2):66–71.

    Article  PubMed  Google Scholar 

  14. Brown HW, Wexner SD, Segall MM, Brezoczky KL, Lukacz ES. Quality of life impact in women with accidental bowel leakage. Int J Clin Pract. 2012;66(11):1109–16.

    Article  CAS  PubMed  Google Scholar 

  15. Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut. 2002;50(4):480–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Roberts RO, Jacobsen SJ, Reilly WT, Pemberton JH, Lieber MM, Talley NJ. Prevalence of combined fecal and urinary incontinence: a community-based study. J Am Geriatr Soc. 1999;47(7):837–41.

    Article  CAS  PubMed  Google Scholar 

  17. Shirran E, Brazzelli M. Absorbent products for the containment of urinary and/or faecal incontinence in adults. Cochrane Database Syst Rev. 2000;(2):CD001406.

    Google Scholar 

  18. Wald A. Diagnosis and management of fecal incontinence. Curr Gastroenterol Rep. 2018;20(3):9.

    Article  PubMed  Google Scholar 

  19. Rosier PF, Gajewski JB, Sand PK, et al. Executive summary: The International Consultation on Incontinence 2008--Committee on: “Dynamic Testing”; for urinary incontinence and for fecal incontinence. Part 1: Innovations in urodynamic techniques and urodynamic testing for signs and symptoms of urinary incontinence in female patients. Neurourol Urodyn. 2010;29(1):140–5.

    Article  PubMed  Google Scholar 

  20. Palmer KR, Corbett CL, Holdsworth CD. Double-blind cross-over study comparing loperamide, codeine and diphenoxylate in the treatment of chronic diarrhea. Gastroenterology. 1980;79(6):1272–5.

    Article  CAS  PubMed  Google Scholar 

  21. Read MG, Krejs GJ, Hendler RS, Davis G, Fordtran JS. A report of five patients with large-volume secretory diarrhea but no evidence of endocrine tumor or laxative abuse. Dig Dis Sci. 1982;27(3):193–201.

    Article  CAS  PubMed  Google Scholar 

  22. Sun WM, Read NW, Verlinden M. Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence. Scand J Gastroenterol. 1997;32(1):34–8.

    Article  CAS  PubMed  Google Scholar 

  23. Cheetham M, Brazzelli M, Norton C, Glazener CM. Drug treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2003;(3):CD002116.

    Google Scholar 

  24. Remes-Troche JM, Ozturk R, Philips C, Stessman M, Rao SS. Cholestyramine – a useful adjunct for the treatment of patients with fecal incontinence. Int J Color Dis. 2008;23(2):189–94.

    Article  Google Scholar 

  25. Wedlake L, A’Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30(7):707–17.

    Article  CAS  PubMed  Google Scholar 

  26. Santora GA, Eitan BZ, Pryde A, Bartolo DC. Open study of low-dose amitriptyline in the treatment of patients with idiopathic fecal incontinence. Dis Colon Rectum. 2000;43(12):1676–81.

    Article  Google Scholar 

  27. Bharucha AE, Fletcher JG, Camilleri M, Edge J, Carlson P, Zinsmeister AR. Effects of clonidine in women with fecal incontinence. Clin Gastroenterol Hepatol. 2014;12(5):843–851.e2.

    Article  CAS  PubMed  Google Scholar 

  28. Bharucha AE, Seide BM, Zinsmeister AR. The effects of clonidine on symptoms and anorectal sensorimotor function in women with faecal incontinence. Aliment Pharmacol Ther. 2010;32(5):681–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7.

    Article  PubMed  Google Scholar 

  30. Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Sys Rev. 2010;(5):CD007959.

    Google Scholar 

  31. Danielson J, Karlbom U, Wester T, Graf W. Efficacy and quality of life 2 years after treatment for faecal incontinence with injectable bulking agents. Tech Coloproctol. 2013;17(4):389–95.

    Article  CAS  PubMed  Google Scholar 

  32. Maeda Y, Laurberg S, Norton C. Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev. 2013;(2):CD007959.

    Google Scholar 

  33. Richter HE, Matthews CA, Muir T, et al. A vaginal bowel-control system for the treatment of fecal incontinence. Obstet Gynecol. 2015;125(3):540–7.

    Article  PubMed  Google Scholar 

  34. Deutekom M, Dobben AC. Plugs for containing faecal incontinence. Cochrane Database Syst Rev. 2015;(7):CD005086.

    Google Scholar 

  35. Lukacz ES, Segall MM, Wexner SD. Evaluation of an anal insert device for the conservative management of fecal incontinence. Dis Colon Rectum. 2015;58(9):892–8.

    Article  PubMed  Google Scholar 

  36. Leroi AM, Siproudhis L, Damon EH, et al. Transcutaneous electrical tibial stimuliation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol. 2012;107(12):1888–96.

    Article  CAS  PubMed  Google Scholar 

  37. Horrocks EJ, Bremner SA, Stevens N, et al. Double-blind randomised controlled trial of percutaneous tibial nerve stimulation versus sham electrical stimulation in the treatment of faecal incontinence: CONtrol of Faecal Incontinence using Distal NeuromodulaTion (the CONFIDeNT trial). Health Technol Assess. 2015;19(77):1–164.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Horrocks EJ, Chadi SA, Stevens NJ, Wexner SD, Knowles CH. Factors associated with efficacy of percutaneous tibial nerve stimulation for fecal incontinence, based on post-hoc analysis of data from a randomized trial. Clin Gastroenterol Hepatol. 2017;15(12):1915–1921.e2.

    Article  PubMed  Google Scholar 

  39. Thin NN, Horrocks EJ, Hotouras A, et al. Systematic review of the clinical effectiveness of neuromodulation in the treatment of faecal incontinence. Br J Surg. 2013;100(11):1430–47.

    Article  CAS  PubMed  Google Scholar 

  40. Horrocks EJ, Thin N, Thaha MA, Taylor SJ, Norton C, Knowles CH. Systematic review of tibial nerve stimulation to treat faecal incontinence. Br J Surg. 2014;101(5):457–68.

    Article  CAS  PubMed  Google Scholar 

  41. Colquhoun P, Kaiser R, Weiss EG, et al. Correlating the Fecal Incontinence Quality-of-Life Score and the SF-36 to a proposed Ostomy Function Index in patients with a stoma. Ostomy Wound Manage. 2006;52(12):68–74.

    PubMed  Google Scholar 

  42. Norton C, Burch J, Kamm MA. Patients’ views of a colostomy for fecal incontinence. Dis Colon Rectum. 2005;48(5):1062–9.

    Article  PubMed  Google Scholar 

  43. Graf W, Mellgren A, Matzel KE, Hull T, Johansson C, Bernstein M, et al. Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial. Lancet. 2011;377(9770):997–1003. PubMed PMID: 21420555.

    Article  CAS  PubMed  Google Scholar 

  44. Mellgren A, Matzel KE, Pollack J, Hull T, Bernstein M, Graf W, et al. Long-term efficacy of NASHA Dx injection therapy for treatment of fecal incontinence. Neurogastroenterol Motil. 2014;26(8):1087–94. PubMed PMID: 24837493. Pubmed Central PMCID: 4371654.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Danielson J, Karlbom U, Sonesson AC, Wester T, Graf W. Submucosal injection of stabilized nonanimal hyaluronic acid with dextranomer: a new treatment option for fecal incontinence. Dis Colon Rectum. 2009;52(6):1101–6. PubMed PMID: 19581853.

    Article  PubMed  Google Scholar 

  46. Dodi G, Jongen J, de la Portilla F, Raval M, Altomare DF, Lehur PA. An open-label, noncomparative, multicenter study to evaluate efficacy and safety of NASHA/Dx gel as a bulking agent for the treatment of fecal incontinence. Gastroenterol Res Pract. 2010;2010:467136. PubMed PMID: 21234379. Pubmed Central PMCID: 3017894.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Schwandner O, Brunner M, Dietl O. Quality of life and functional results of submucosal injection therapy using dextranomer hyaluronic acid for fecal incontinence. Surg Innov. 2011;18(2):130–5. PubMed PMID: 21245071.

    Article  PubMed  Google Scholar 

  48. Ratto C, Buntzen S, Aigner F, Altomare DF, Heydari A, Donisi L, et al. Multicentre observational study of the Gatekeeper for faecal incontinence. Br J Surg. 2016;103(3):290–9. PubMed PMID: 26621029. Pubmed Central PMCID: 5063193.

    Article  CAS  PubMed  Google Scholar 

  49. Trenti L, Biondo S, Noguerales F, Nomdedeu J, Coret A, Scherer R, et al. Outcomes of Gatekeeper(TM) prosthesis implantation for the treatment of fecal incontinence: a multicenter observational study. Tech Coloproctol. 2017;21(12):963–70.

    Article  PubMed  Google Scholar 

  50. de la Portilla F, Reyes-Diaz ML, Maestre MV, Jimenez-Rodriguez RM, Garcia-Cabrera AM, Vazquez-Monchul JM, et al. Ultrasonographic evidence of Gatekeeper prosthesis migration in patients treated for faecal incontinence: a case series. Int J Color Dis. 2017;32(3):437–40. PubMed PMID: 28054134.

    Article  Google Scholar 

  51. Efron JE, Corman ML, Fleshman J, Barnett J, Nagle D, Birnbaum E, et al. Safety and effectiveness of temperature-controlled radio-frequency energy delivery to the anal canal (Secca procedure) for the treatment of fecal incontinence. Dis Colon Rectum. 2003;46(12):1606–16; discussion 16–8. PubMed PMID: 14668584.

    Article  PubMed  Google Scholar 

  52. Felt-Bersma RJ, Szojda MM, Mulder CJ. Temperature-controlled radiofrequency energy (SECCA) to the anal canal for the treatment of faecal incontinence offers moderate improvement. Eur J Gastroenterol Hepatol. 2007;19(7):575–80. PubMed PMID: 17556904.

    Article  PubMed  Google Scholar 

  53. Lefebure B, Tuech JJ, Bridoux V, Gallas S, Leroi AM, Denis P, et al. Temperature-controlled radio frequency energy delivery (Secca procedure) for the treatment of fecal incontinence: results of a prospective study. Int J Color Dis. 2008;23(10):993–7.

    Article  CAS  Google Scholar 

  54. Kim DW, Yoon HM, Park JS, Kim YH, Kang SB. Radiofrequency energy delivery to the anal canal: is it a promising new approach to the treatment of fecal incontinence? Am J Surg. 2009;197(1):14–8.

    Article  PubMed  Google Scholar 

  55. Ruiz D, Pinto RA, Hull TL, Efron JE, Wexner SD. Does the radiofrequency procedure for fecal incontinence improve quality of life and incontinence at 1-year follow-up? Dis Colon Rectum. 2010;53(7):1041–6. PubMed PMID: 20551757.

    Article  PubMed  Google Scholar 

  56. Abbas MA, Tam MS, Chun LJ. Radiofrequency treatment for fecal incontinence: is it effective long-term? Dis Colon Rectum. 2012;55(5):605–10. PubMed PMID: 22513440.

    Article  PubMed  Google Scholar 

  57. Lam TJ, Visscher AP, Meurs-Szojda MM, Felt-Bersma RJ. Clinical response and sustainability of treatment with temperature-controlled radiofrequency energy (Secca) in patients with faecal incontinence: 3 years follow-up. Int J Color Dis. 2014;29(6):755–61. PubMed PMID: 24805249.

    Article  CAS  Google Scholar 

  58. Takahashi-Monroy T, Morales M, Garcia-Osogobio S, Valdovinos MA, Belmonte C, Barreto C, et al. SECCA procedure for the treatment of fecal incontinence: results of five-year follow-up. Dis Colon Rectum. 2008;51(3):355–9. PubMed PMID: 18204954.

    Article  PubMed  Google Scholar 

  59. Visscher AP, Lam TJ, Meurs-Szojda MM, Felt-Bersma RJF. Temperature-controlled delivery of radiofrequency energy in fecal incontinence: a randomized sham-controlled clinical trial. Dis Colon Rectum. 2017;60(8):860–5. PubMed PMID: 28682972.

    Article  PubMed  Google Scholar 

  60. Takahashi T, Garcia-Osogobio S, Valdovinos MA, Belmonte C, Barreto C, Velasco L. Extended two-year results of radio-frequency energy delivery for the treatment of fecal incontinence (The Secca Procedure). Dis Colon Rectum. 2003;46(6):711–5.

    Article  PubMed  Google Scholar 

  61. Takahashi T, Garcia-Osogobio S, Valdovinos MA, Mass W, Jimenez R, Jauregui LA, Bobadilla J, Belmonte C, Edelstein PS, Utley DS. Radio-frequency energy delivery to the anal canal for the treatment of fecal incontinence. Dis Colon Rectum. 2002;45(7):915–22.

    Article  PubMed  Google Scholar 

  62. Walega P, Romaniszyn M, Siarkiewicz B, Zelazny D. Dynamic versus adynamic graciloplasty in treatment of end-stage fecal incontinence: is the implantation of the pacemaker really necessary? 12-month follow-up in a clinical, physiological, and functional study. Gastroenterol Res Pract. 2015;2015:698516.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Alavi K, Chan S, Wise P, Kaiser AM, Sudan R, Bordeianou L. Fecal incontinence: etiology, diagnosis, and management. J Gastrointest Surg. 2015;19(10):1910–21. PubMed PMID: 26268955.

    Google Scholar 

  64. Freeman A, Menees S. Fecal incontinence and pelvic floor dysfunction in women: a review. Gastroenterol Clin North Am. 2016;45(2):217–37.

    Google Scholar 

  65. Murad-Regadas SM, Regadas FSP, Regadas Filho FSP, Mendonça Filho JJ, Andrade Filho RS, Vilarinho ADS. Predictors of unsuccessful treatment for fecal incontinence biofeedback in females. Arq Gastroenterol. 2019;56(1):61–5.

    Google Scholar 

  66. Wald A. Diagnosis and management of fecal incontinence. Curr Gastroenterol Rep. 2018;20(3):9.

    Google Scholar 

  67. Sanagapalli S, Harrington S, Zarate-Lopez N, Emmanuel A. Posterior tibial nerve stimulation for the treatment of fecal incontinence following obstetric anal sphincter injury. Neuromodulation. 2018;21(7):688–93.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dana R. Sands .

Editor information

Editors and Affiliations

Commentary

Commentary

Fecal incontinence (FI) as outlined in this chapter is not uncommon. The etiology is multifactorial, and treatment is individualized for each patient. Therefore, a comprehensive history is the first step in caring for this group of patients. Physical exam further refines treatment possibilities [63].

Some FI results from inflammatory conditions like ulcerative colitis. Treatment of the primary inflammatory process is the initial therapy. Otherwise, most treatment recommendations begin with a combination of nonsurgical approaches, which are discussed in detail in this chapter. The goal should aim toward total continence. Many studies determine successful results as 50% reduction in incontinent episodes. While a 50% reduction may be an improvement, any accidental episodes of FI can be humiliating and demoralizing.

Loose stools are a factor for many patients with FI, and strategies to minimize diarrhea are part of most recommendations. As mentioned, anal skin care with protective barrier creams is sometimes a forgotten component of treatment [64]. Physical therapy utilizing auditory and/or visual feedback emphasizes retraining for improved anal strength, pelvic coordination, and optimization of rectal sensitivity. This therapy can be operator dependent and time intensive to produce an acceptable outcome. Enemas or rectal washout is also a treatment strategy that may be successfully utilized for selected patients who are motivated to use this therapy [65, 66]. As outlined in the chapter, a combination of these treatments is part of the individual approach.

To further optimize quality of life, other nonsurgical approaches may be considered. While insertion of devices into the vagina in women or anal inserts seem like attractive options to prevent stool from being expelled at unwanted times, both success and tolerance have been suboptimal [66].

With the success of sacral nerve modulation, percutaneous tibial nerve stimulation seems like an attractive less invasive treatment that should stimulate similar nerve pathways. Results have not been straightforward, but as discussed in the chapter, selective patients may benefit [67].

Nonsurgical therapies are overall safe and do not burn bridges for other therapies. For patients who have failed all treatment options or are not candidates for other therapies, fecal diversion allows patients the ability to leave home, work, and attend social functions. A stoma should not be viewed as a failure, but instead as a means to improve quality of life in this group of patients [66].

As mentioned in this chapter, critical examination of studies regarding FI is essential when determining efficacy of therapy. As with many areas of pelvic floor research, patient selection for studies may not appropriately compare like patients, especially those with FI. FI is difficult to treat. Appraisal of the characteristics of patient included in studies and the primary aim should be scrutinized before fully dismissing a treatment with minimal risk to patients with FI.

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lao, V.V., Sands, D.R. (2021). Treatment for Fecal Incontinence: Nonsurgical Approaches. In: Kobashi, K.C., Wexner, S.D. (eds) Female Pelvic Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-54839-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54839-1_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54838-4

  • Online ISBN: 978-3-030-54839-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics